Ghent University Academic Bibliography

Your filters: cql: author="Vanderkerken, Karin" or (type any "bookEditor issueEditor" and editor="Vanderkerken, Karin")

Add to list
- Journal Article
- A1
- open access
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy

Arne van der Vreken, Fabien Henri Thery (UGent) , Chenggong Tu, Kevin Mwangi (UGent) , Sofie Meulewaeter (UGent) , Lien De Beck, Edith Janssens, Kim De Veirman, Karin Vanderkerken, Elke De Bruyne, et al.

(2025) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 13(4).
Add to list
- Journal Article
- A1
- open access
A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages

Emma Verheye, Daliya Kancheva, Hatice Satilmis, Niels Vandewalle, Rong Fan, Pauline M. R. Bardet, Emile J. Clappaert, Kevin Verstaen (UGent) , Ann De Becker, Karin Vanderkerken, et al.

(2024) JOURNAL OF HEMATOLOGY & ONCOLOGY. 17(1).
Add to list
- Conference Paper
- C3
AXL-specific single domain antibodies show diagnostic potential and antitumor activity in acute myeloid leukemia

Niels Vandewalle, Hatice Satilmis, Emma M. Verheye, Rong Fan, Yanmeng Wang, Timo W. De Groof, Tessa Kerre (UGent) , Nathan De Beule, Ann De Becker, Elke De Bruyne, et al.

(2024) CANCER RESEARCH. In Cancer Research 84(6, Supplement S).
Add to list
- Journal Article
- A1
- open access
Pyrroline-5-carboxylate reductase 1 : a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

Inge Oudaert, Hatice Satilmis, Philip Vlummens (UGent) , Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquiere, Karin Vanderkerken, Kim De Veirman, et al.

(2022) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 41(1).
Add to list
- Journal Article
- A1
- open access
System Xc(-) inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance

Fang Wang, Inge Oudaert, Chenggong Tu, Anke Maes, Arne Van Der Vreken, Philip Vlummens (UGent) , Elke De Bruyne, Kim De Veirman, Yanmeng Wang, Rong Fan, et al.

(2022) CANCER LETTERS. 535.
Add to list
- Journal Article
- A1
- open access
The use of murine models for studying mechanistic insights of genomic instability in multiple myeloma

Philip Vlummens (UGent) , Kim De Veirman, Eline Menu, Elke De Bruyne, Fritz Offner (UGent) , Karin Vanderkerken and Ken Maes

(2019) FRONTIERS IN GENETICS. 10.
Add to list
- Journal Article
- A1
- open access
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

Anke Maes, Ken Maes, Philip Vlummens (UGent) , Hendrik De Raeve, Julie Devin, Vanessa Szablewski, Kim De Veirman, Eline Menu, Jerome Moreaux, Karin Vanderkerken, et al.

(2019) BLOOD CANCER JOURNAL. 9.
Add to list
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

Kim De Veirman, Eline Menu, Ken Maes, Nathan De Beule, Eva De Smedt, Anke Maes, Philip Vlummens (UGent) , Karel Fostier, Alboukadel Kassambara, Jerome Moreaux, et al.

(2019) CANCER LETTERS. 442. p.233-241
Add to list
- Journal Article
- A1
- open access
The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma

Sylvia Faict, Inge Oudaert, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens (UGent) , Kim De Veirman, Elke De Bruyne, Karel Fostier, Isabelle Vande Broek, et al.

(2019) CANCERS. 11(12).
Add to list
- Conference Paper
- C3
The exosomal transfer of acid sphingomyelinase contributes to drug resistance in multiple myeloma

Inge Oudaert, Sylvia Faict, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens (UGent) , Lotte Jacobs, Kim De Veirman, Elke De Bruyne, Karel Fostier, et al.

(2019) BLOOD. 134.

Academic Bibliography

Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy

A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages

AXL-specific single domain antibodies show diagnostic potential and antitumor activity in acute myeloid leukemia

Pyrroline-5-carboxylate reductase 1 : a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

System Xc(-) inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance

The use of murine models for studying mechanistic insights of genomic instability in multiple myeloma

Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma

The exosomal transfer of acid sphingomyelinase contributes to drug resistance in multiple myeloma

Contents

Support

Contact